NTRK1 and neoplasm: Importantly, Ntrk1 is a top hit across both time points of tumor collection and sequencing, suggesting the validity of this gene as a positive hit from the screen that is more likely to play a role in PD-1 treatment resistance in the face of long-term treatments.